Giulia Tosato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giulia Tosato has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Basso
Department of cardiac, Thoracic and Vascular sciences and Public Health, University of Padua , Padova
4 shared publications - Kalliopi Pilichou
Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University of Padua, Italy (R.C., K.P.).
4 shared publications - Marco Cason
University of Padua
4 shared publications - Serena Pinci
University of Padua
4 shared publications - Francesca Dalla Zanna
Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University of Padua, Via A. Gabelli 61, 35121, Padova, Italy
3 shared publications - Gaetano Thiene
Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy
3 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
A zebrafish stable model of Galectin-3 to elucidate its role in arrhythmogenic cardiomyopathy
Galectin-3 (Gal-3) dysregulation has emerged as a critical mediator of inflammatory processes in arrhythmogenic cardiomyopathy (AC), playing pivotal roles in modulating Wnt/β-catenin signaling and regulating macrophage polarization. AC is a rare genetic disorder, primarily driven by desmosomal gene variants, characterized by fibro-fatty replacement of the ventricular myocardium, progressive ventricular dysfunction, and heightened arrhythmic risk in the young and athletes. To investigate the role of this multifaceted lectin in AC pathogenesis, we developed and characterized a stable lgals3a (-aa) knock-out zebrafish model. lgals3a deficiency recapitulated several AC-like pathological features, including ventricular adipose infiltration, chamber dilation, pericardial effusion, and rhythm abnormalities from larval to adult stages. Ultrastructural analyses revealed disrupted desmosomes, directly implicating Gal-3 in intercellular adhesion independent of other desmosomal gene variants. Transcriptomic analyses demonstrated suppression of both Wnt/β-catenin and TGFβ signaling. Early-stage pharmacological activation of Wnt signaling partially rescued cardiac function, whereas structural defects persisted in adults, indicating that therapeutic efficacy is strongly dependent on disease stage and timing of intervention. Inflammatory profiling revealed significant immune cell infiltration and upregulation of macrophage-related proinflammatory genes (i.e., mmp25b and il12rb2), consistent with AC “hot phases”. This study revealed lgals3a deficiency as a contributor to AC-like pathological features in zebrafish and supports a role for Gal-3 in maintaining cardiac intercellular adhesion, inflammatory homeostasis, and cardiac function.
- 24 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessA zebrafish stable model of Galectin-3 to elucidate its role in arrhythmogenic cardiomyopathy
Galectin-3 (Gal-3) dysregulation has emerged as a critical mediator of inflammatory processes in arrhythmogenic cardiomyopathy (AC), playing pivotal roles in modulating Wnt/β-catenin signaling and regulating macrophage polarization. AC is a rare genetic disorder, primarily driven by desmosomal gene variants, characterized by fibro-fatty replacement of the ventricular myocardium, progressive ventricular dysfunction, and heightened arrhythmic risk in the young and athletes. To investigate the role of this multifaceted lectin in AC pathogenesis, we developed and characterized a stable lgals3a (-aa) knock-out zebrafish model. lgals3a deficiency recapitulated several AC-like pathological features, including ventricular adipose infiltration, chamber dilation, pericardial effusion, and rhythm abnormalities from larval to adult stages. Ultrastructural analyses revealed disrupted desmosomes, directly implicating Gal-3 in intercellular adhesion independent of other desmosomal gene variants. Transcriptomic analyses demonstrated suppression of both Wnt/β-catenin and TGFβ signaling. Early-stage pharmacological activation of Wnt signaling partially rescued cardiac function, whereas structural defects persisted in adults, indicating that therapeutic efficacy is strongly dependent on disease stage and timing of intervention. Inflammatory profiling revealed significant immune cell infiltration and upregulation of macrophage-related proinflammatory genes (i.e., mmp25b and il12rb2), consistent with AC “hot phases”. This study revealed lgals3a deficiency as a contributor to AC-like pathological features in zebrafish and supports a role for Gal-3 in maintaining cardiac intercellular adhesion, inflammatory homeostasis, and cardiac function.
- Open Access
- 20 June 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Tackling non-canonical splicing in arrhythmogenic cardiomyopathy to reduce the uncertain significance variants burden
Splice-altering variants (SAVs), particularly those outside canonical splice sites, are an underappreciated contributor to inherited cardiovascular diseases. In arrhythmogenic cardiomyopathy (ACM), these variants frequently remain classified as of uncertain significance (VUS) due to limited predictive power and lack of transcript-level evidence, constraining genetic yield and clinical management. Our study aimed to determine the functional impact of SAVs in ACM genes and refine their classification using ACMG/AMP and ClinGen SVI criteria. SAVs identified in 200 ACM probands underwent SpliceAI prediction, GTEx cardiac exon-usage annotation, and functional assessment using pSPL3-based minigene assays. Aberrant transcripts were quantified using Percent Splicing Alteration (PSA). Segregation data and ACMG/AMP criteria refined by ClinGen SVI were applied to integrate functional and clinical evidence for classification. Aberrant splicing was confirmed in 9/20 variants (45%), including synonymous, missense, and non-canonical intronic changes. SpliceAI scores correlated strongly with PSA values (R²=0.86). Case-control burden testing revealed significant enrichment of splice-altering variants in DSP, DSG2, DSC2 and FLNC. Integrating predictive algorithms with experimental validation and segregation analysis markedly enhances reclassification of 16/20 variants (80%). Splicing defects beyond canonical sites significantly shape ACM genetic landscape. Integrating predictive models with experimental validation clarifies uncertain variants bridging the gap between genomic uncertainty and clinical decision-making.
- 20 June 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessTackling non-canonical splicing in arrhythmogenic cardiomyopathy to reduce the uncertain significance variants burden
Splice-altering variants (SAVs), particularly those outside canonical splice sites, are an underappreciated contributor to inherited cardiovascular diseases. In arrhythmogenic cardiomyopathy (ACM), these variants frequently remain classified as of uncertain significance (VUS) due to limited predictive power and lack of transcript-level evidence, constraining genetic yield and clinical management. Our study aimed to determine the functional impact of SAVs in ACM genes and refine their classification using ACMG/AMP and ClinGen SVI criteria. SAVs identified in 200 ACM probands underwent SpliceAI prediction, GTEx cardiac exon-usage annotation, and functional assessment using pSPL3-based minigene assays. Aberrant transcripts were quantified using Percent Splicing Alteration (PSA). Segregation data and ACMG/AMP criteria refined by ClinGen SVI were applied to integrate functional and clinical evidence for classification. Aberrant splicing was confirmed in 9/20 variants (45%), including synonymous, missense, and non-canonical intronic changes. SpliceAI scores correlated strongly with PSA values (R²=0.86). Case-control burden testing revealed significant enrichment of splice-altering variants in DSP, DSG2, DSC2 and FLNC. Integrating predictive algorithms with experimental validation and segregation analysis markedly enhances reclassification of 16/20 variants (80%). Splicing defects beyond canonical sites significantly shape ACM genetic landscape. Integrating predictive models with experimental validation clarifies uncertain variants bridging the gap between genomic uncertainty and clinical decision-making.
- Open Access
- 6 February 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Integrative genomic and literature assessment of desmoglein 2-related arrhythmogenic cardiomyopathy with Italian cohort validation
Background Desmoglein-2 (DSG2) is an essential cardiac desmosomal cadherin, and its alteration underlies a broad spectrum of arrhythmogenic cardiomyopathy (ACM). Yet, the clinical significance of many DSG2 variants remains uncertain. This study aimed to systematically characterize the spectrum, structural impact, and clinical relevance of DSG2 variants by integrating large-scale genomic evidence, published data, and a deeply phenotyped validation cohort. Methods We conducted a systematic literature review (115 studies; 145 curated variants) and analyzed population-scale datasets (3570 variants in gnomAD; 1847 in ClinVar). All variants were uniformly reclassified following ACMG/ClinGen criteria. A validation cohort of 95 Italian DSG2-carriers underwent detailed phenotyping. Structural modeling via AlphaFold, supported protein modeling, calcium-binding site prediction, and DynaMut stability analysis were performed to evaluate the functional consequences of key variants. Results Literature and database integration reveal domain-specific variant clustering, with high-impact missense variants enriched in calcium-binding extracellular domains, the furin cleavage site, and the intracellular PKP2-binding region. In the validation cohort, penetrance among genotype-positive relatives is 42%, while 13% of definite ACM cases experience major ventricular arrhythmias; transplantation and mortality each occur in 3%. Biallelic and digenic variants are associated with earlier onset and more severe biventricular involvement. Structural modeling confirms that pathogenic missense substitutions destabilize DSG2 architecture or impair calcium-dependent adhesion. Conclusions This study refines the classification of DSG2 variants and highlights the importance of domain-level and multilocus interpretation in ACM. These findings support comprehensive genetic screening, structural modeling for variant assessment, and lifelong follow-up of DSG2 carriers to improve diagnosis and risk stratification.
- 6 February 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Open AccessIntegrative genomic and literature assessment of desmoglein 2-related arrhythmogenic cardiomyopathy with Italian cohort validation
Background Desmoglein-2 (DSG2) is an essential cardiac desmosomal cadherin, and its alteration underlies a broad spectrum of arrhythmogenic cardiomyopathy (ACM). Yet, the clinical significance of many DSG2 variants remains uncertain. This study aimed to systematically characterize the spectrum, structural impact, and clinical relevance of DSG2 variants by integrating large-scale genomic evidence, published data, and a deeply phenotyped validation cohort. Methods We conducted a systematic literature review (115 studies; 145 curated variants) and analyzed population-scale datasets (3570 variants in gnomAD; 1847 in ClinVar). All variants were uniformly reclassified following ACMG/ClinGen criteria. A validation cohort of 95 Italian DSG2-carriers underwent detailed phenotyping. Structural modeling via AlphaFold, supported protein modeling, calcium-binding site prediction, and DynaMut stability analysis were performed to evaluate the functional consequences of key variants. Results Literature and database integration reveal domain-specific variant clustering, with high-impact missense variants enriched in calcium-binding extracellular domains, the furin cleavage site, and the intracellular PKP2-binding region. In the validation cohort, penetrance among genotype-positive relatives is 42%, while 13% of definite ACM cases experience major ventricular arrhythmias; transplantation and mortality each occur in 3%. Biallelic and digenic variants are associated with earlier onset and more severe biventricular involvement. Structural modeling confirms that pathogenic missense substitutions destabilize DSG2 architecture or impair calcium-dependent adhesion. Conclusions This study refines the classification of DSG2 variants and highlights the importance of domain-level and multilocus interpretation in ACM. These findings support comprehensive genetic screening, structural modeling for variant assessment, and lifelong follow-up of DSG2 carriers to improve diagnosis and risk stratification.
- Open Access
- 27 August 2025
- Published by Springer Nature in Research Square
Desmoglein-2 related Arrhythmogenic Cardiomyopathy: Integrative Genomic and Literature-based analysis with an Italian cohort-Level Validation
Desmoglein-2 (DSG2) is a crucial desmosomal cadherin expressed in cardiomyocytes that contributes significantly to the development of arrhythmogenic cardiomyopathy (ACM), a condition characterized by variable onset and clinical presentation. In this study, we conducted an integrative analysis that merges a systematic review of the literature, data from large-scale population databases, and findings from a well-phenotyped Italian ACM validation cohort (n = 95). While pathogenic variants, “hot-VUS,” and copy number alterations were primarily located in calcium-binding extracellular domains, the furin cleavage site, and cytoplasmic anchoring motifs, these alone were insufficient to explain disease manifestation, with penetrance estimated at just 42%. In contrast, biallelic and digenic variants correlated with earlier onset, more severe biventricular involvement, and complete penetrance. Structural modeling and protein stability analyses confirmed disruption of key functional domains. These results underscore the complexity of DSG2-related ACM and advocate for domain- and multilocus-informed diagnostic strategies, along with comprehensive genetic screening and sustained clinical follow-up for effective risk stratification in affected families.
- 27 August 2025
- Published by Springer Nature in Research Square
Open AccessDesmoglein-2 related Arrhythmogenic Cardiomyopathy: Integrative Genomic and Literature-based analysis with an Italian cohort-Level Validation
Desmoglein-2 (DSG2) is a crucial desmosomal cadherin expressed in cardiomyocytes that contributes significantly to the development of arrhythmogenic cardiomyopathy (ACM), a condition characterized by variable onset and clinical presentation. In this study, we conducted an integrative analysis that merges a systematic review of the literature, data from large-scale population databases, and findings from a well-phenotyped Italian ACM validation cohort (n = 95). While pathogenic variants, “hot-VUS,” and copy number alterations were primarily located in calcium-binding extracellular domains, the furin cleavage site, and cytoplasmic anchoring motifs, these alone were insufficient to explain disease manifestation, with penetrance estimated at just 42%. In contrast, biallelic and digenic variants correlated with earlier onset, more severe biventricular involvement, and complete penetrance. Structural modeling and protein stability analyses confirmed disruption of key functional domains. These results underscore the complexity of DSG2-related ACM and advocate for domain- and multilocus-informed diagnostic strategies, along with comprehensive genetic screening and sustained clinical follow-up for effective risk stratification in affected families.